相关实验视频
Updated: Jun 9, 2025

02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.2K
神经学实践中的阿片类药物和大麻素
概括
治疗慢性疼痛的阿片类药物和大麻素疗法存在争议. 了解风险和实施缓解策略,如仔细选择和监测患者,对于优化神经病痛管理结果至关重要.
科学领域:
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 在疼痛治疗中,向生物心理社会模式的转变减少了对慢性疼痛阿片类药物治疗的依赖.
- 增加的阿片类药物过量死亡和阿片类药物使用障碍与处方做法和非法药物使用有关,特别是芬太尼.
- 在美国,治疗慢性疼痛的大麻素使用量有所增加.
研究的目的:
- 探索阿片类药物和大麻类药物治疗慢性疼痛的有争议的使用,特别是神经病痛.
- 了解患者和处方因素影响与这些疗法相关的风险.
- 突出风险减轻策略在优化治疗结果方面的重要性.
主要方法:
- 审查目前的阿片类药物治疗指南和最佳实践,包括疾病控制和预防中心 (CDC) 的建议.
- 检查阿片类药物治疗的风险减轻策略,如患者选择,教育,处方药监测和纳洛.
- 评估证据支持大麻素对神经病痛的疗效.
主要成果:
- 通常不建议在慢性神经病痛中使用阿片类药物治疗,但在严重病例中可以考虑短期使用,作为多模式治疗方法的一部分.
- 有效的阿片类药物风险减轻策略包括仔细评估患者,知情同意,处方药监测,尿液药物检测和纳洛.
- 大麻素显示出神经病痛疗效的证据,在特定患者群体中具有积极反应率.
结论:
- 阿片类药物治疗需要严格的降低风险,并密切监测慢性神经病痛的患者.
- 对于一些神经病痛患者来说,大麻素是一种可行的治疗选择.
- 综合患者因素和风险管理的综合方法对于有效的慢性疼痛治疗至关重要.
相关概念视频
Analgesia and Pain Management
534
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
534
Opioid Analgesics: Synthetic and Semisynthetic Opioids
234
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
234
Opioid Analgesics: Morphine and Other Natural Cogeners
187
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
187
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
165
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
165
Opioid Receptors: Overview
549
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
549
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
202
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
202

